Medical Developments International | MVP - Zahlungsmittel Und Äquivalente

Aktienkurs
0.46
Täglich Wechseln
0.02 3.41%
Monatlich
10.98%
Jährlich
-28.91%
Q2 Prognose
0.51




Zahlungsmittel Und Äquivalente Veränderung Datum
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Alaunos Therapeutics USD 1.38M 553K 2025-12
Avita Medical AUD 10.24M 1.98M 2025-12
Clinuvel Pharmaceuticals AUD 35.2M 3.62M 2024-06
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Genetic Signatures AUD 7.47M 33.32M 2025-06
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Medical Developments International AUD 17.84M 219K 2025-06
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organon & Co USD 574M 98M 2025-12
Paradigm Biopharmaceuticals AUD 16.82M 1M 2025-06
PYC Therapeutics AUD 153.05M 103.8M 2025-06
Starpharma Holdings AUD 15.41M 4.87M 2025-06
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Telix Pharmaceuticals AUD 207.16M 503.19M 2025-06
Viatris USD 1.32B 347.1M 2025-12
Xeris Pharmaceuticals USD 111.04M 19.44M 2025-12